↓ Skip to main content

Cochrane Database of Systematic Reviews

Pregabalin for chronic prostatitis

Overview of attention for article published in Cochrane database of systematic reviews, August 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
101 Mendeley
Title
Pregabalin for chronic prostatitis
Published in
Cochrane database of systematic reviews, August 2012
DOI 10.1002/14651858.cd009063.pub2
Pubmed ID
Authors

Omar M Aboumarzouk, Richard L Nelson

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a condition that is detrimental to the quality of life of men. Evidence suggests that it may have a neuropathic origin and therefore medications such as pregabalin might have a role in the controlling of symptoms.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 2%
Unknown 99 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 17%
Student > Bachelor 12 12%
Student > Doctoral Student 10 10%
Other 7 7%
Professor 5 5%
Other 18 18%
Unknown 32 32%
Readers by discipline Count As %
Medicine and Dentistry 35 35%
Nursing and Health Professions 7 7%
Agricultural and Biological Sciences 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Psychology 3 3%
Other 11 11%
Unknown 36 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#7,077,903
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,164
of 11,499 outputs
Outputs of similar age
#50,533
of 186,216 outputs
Outputs of similar age from Cochrane database of systematic reviews
#133
of 207 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,216 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 207 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.